KINISOQUIN Trademark

Trademark Overview

On Monday, March 16, 2020, a trademark application was filed for KINISOQUIN with the United States Patent and Trademark Office. The USPTO has given the KINISOQUIN trademark a serial number of 88836223. The federal status of this trademark filing is SU - NON-FINAL ACTION - MAILED as of Monday, June 3, 2024. This trademark is owned by Quercis Pharma AG. The KINISOQUIN trademark is filed in the Pharmaceutical Products category with the following description:

PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF THROMBOSIS, SICKLE CELL DISEASE, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, AMYOTROPHIC LATERAL SCLEROSIS, PANCREATIC CANCER, OVARIAN CANCER, EBOLA VIRUS AND COVID-19
kinisoquin

General Information

Serial Number88836223
Word MarkKINISOQUIN
Filing DateMonday, March 16, 2020
Status807 - SU - NON-FINAL ACTION - MAILED
Status DateMonday, June 3, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 2, 2021

Trademark Statements

Goods and ServicesPHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF THROMBOSIS, SICKLE CELL DISEASE, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, AMYOTROPHIC LATERAL SCLEROSIS, PANCREATIC CANCER, OVARIAN CANCER, EBOLA VIRUS AND COVID-19
Translation of Words in MarkThe wording "KINISOQUIN" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, March 20, 2020
Primary Code005
First Use Anywhere DateMonday, June 22, 2020
First Use In Commerce DateMonday, June 22, 2020

Trademark Owner History

Party NameQuercis Pharma AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressZug 6300
CH
Party NameQuercis Pharma AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressZug 6300
CH

Trademark Events

Event DateEvent Description
Thursday, March 19, 2020NEW APPLICATION ENTERED
Friday, March 20, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, July 15, 2020ASSIGNED TO EXAMINER
Friday, July 17, 2020NON-FINAL ACTION WRITTEN
Friday, July 17, 2020NON-FINAL ACTION E-MAILED
Friday, July 17, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, July 30, 2020NON-FINAL ACTION WRITTEN
Thursday, July 30, 2020NON-FINAL ACTION E-MAILED
Thursday, July 30, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, January 20, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, January 20, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, January 21, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, January 22, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 10, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 2, 2021PUBLISHED FOR OPPOSITION
Tuesday, March 2, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 27, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, October 27, 2021SOU TEAS EXTENSION RECEIVED
Wednesday, October 27, 2021SOU EXTENSION 1 FILED
Wednesday, October 27, 2021SOU EXTENSION 1 GRANTED
Wednesday, April 27, 2022SOU EXTENSION 2 FILED
Friday, October 29, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 30, 2022ABANDONMENT - NO USE STATEMENT FILED
Tuesday, May 31, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Tuesday, June 28, 2022TEAS PETITION TO REVIVE RECEIVED
Tuesday, June 28, 2022PETITION TO REVIVE-GRANTED
Tuesday, June 28, 2022SOU EXTENSION RECEIVED WITH TEAS PETITION
Tuesday, June 28, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, June 28, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, June 28, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, June 28, 2022TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Tuesday, June 28, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, June 28, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, June 28, 2022NOTICE OF REVIVAL - E-MAILED
Wednesday, July 27, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, July 27, 2022SOU EXTENSION 2 GRANTED
Thursday, July 28, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 26, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, October 26, 2022SOU EXTENSION 3 FILED
Wednesday, October 26, 2022SOU EXTENSION 3 GRANTED
Friday, October 28, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 27, 2023SOU TEAS EXTENSION RECEIVED
Thursday, April 27, 2023SOU EXTENSION 4 FILED
Thursday, April 27, 2023SOU EXTENSION 4 GRANTED
Saturday, April 29, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 20, 2023SOU TEAS EXTENSION RECEIVED
Friday, October 20, 2023SOU EXTENSION 5 FILED
Friday, October 27, 2023SOU EXTENSION 5 GRANTED
Saturday, October 28, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 29, 2024TEAS STATEMENT OF USE RECEIVED
Monday, April 29, 2024USE AMENDMENT FILED
Friday, May 3, 2024STATEMENT OF USE PROCESSING COMPLETE
Monday, June 3, 2024SU - NON-FINAL ACTION - WRITTEN
Monday, June 3, 2024NON-FINAL ACTION E-MAILED
Monday, June 3, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED

Related Keywords

kinisoquin cancer disease pancreatic sclerosis lateral ovarian covid virus ebola amyotrophic